靶向趋化因子受体CXCR4的分子影像引导急性心肌梗死后修复
该研究在小鼠心肌梗死模型中用PET成像表征梗死区CXCR4表达,发现其早期上调可预测左室破裂和慢性收缩功能障碍;在CXCR4表达高峰时给予AMD3100阻断可降低破裂发生率并改善6周收缩功能,而延迟给药无效。50例急性心梗患者中梗死区CXCR4表达与收缩功能相关,支持影像引导的诊疗一体化策略。
要点
- 心梗后早期CXCR4表达上调可预测左室破裂和慢性收缩功能障碍。
- 在CXCR4表达高峰时阻断可减少破裂并改善收缩功能,延迟给药无效。
- 急性心梗患者梗死区CXCR4表达与收缩功能相关。
核心结论
- PET成像可识别心梗后早期CXCR4上调,其可预测急性左室破裂和慢性收缩功能障碍。
- 影像引导的CXCR4抑制可加速炎症消退并改善结局,支持基于分子影像的诊疗一体化策略。
研究设计与样本
- 小鼠研究共180只,接受冠状动脉结扎或假手术,并进行连续7天PET成像。
- 小鼠接受CXCR4阻断剂AMD3100治疗,分别在3天(高峰期)或7天(非高峰期)给药。
- 患者研究纳入50例急性心梗早期患者,接受CXCR4 PET成像和功能评估。
主要发现
- 小鼠心梗后梗死区CXCR4含量在3天内升高,第1天为1.1±0.2 %ID/g、第3天为0.9±0.2 %ID/g,假手术组为0.6±0.1 %ID/g,P<0.001。
- 死于左室破裂的小鼠第3天炎症持续存在,CXCR4信号为1.2±0.3 %ID/g,存活者为0.9±0.2 %ID/g,P<0.001。
- 第1天和第3天较高的CXCR4信号独立预测6周时更差的功能结局(rpartial=-0.4,P=0.04)。
- 第3天高峰期CXCR4阻断使左室破裂发生率从25%降至8%,6周收缩功能改善+24%(P=0.01);第7天非高峰期阻断未改善结局。
- 流式细胞术显示高峰期治疗后左室中性粒细胞和Ly6Chigh单核细胞含量降低。
临床怎么用
- 急性心梗后可通过CXCR4 PET成像早期识别高危患者,预测左室破裂和慢性收缩功能障碍。
- CXCR4阻断治疗需在表达高峰早期(如3天)给予,延迟给药可能无效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Balance between inflammatory and reparative leucocytes allows optimal healing after myocardial infarction (MI). Interindividual heterogeneity evokes variable functional outcome complicating targeted therapy. We aimed to characterize infarct chemokine CXC-motif receptor 4 (CXCR4) expression using positron emission tomography (PET) and establish its relationship to cardiac outcome. We tested whether image-guided early CXCR4 directed therapy attenuates chronic dysfunction. METHODS AND RESULTS: Mice (n = 180) underwent coronary ligation or sham surgery and serial PET imaging over 7 days. Infarct CXCR4 content was elevated over 3 days after MI compared with sham (%ID/g, Day 1:1.1 ± 0.2; Day 3:0.9 ± 0.2 vs. 0.6 ± 0.1, P < 0.001), confirmed by flow cytometry and histopathology. Mice that died of left ventricle (LV) rupture exhibited persistent inflammation at 3 days compared with survivors (1.2 ± 0.3 vs. 0.9 ± 0.2% ID/g, P < 0.001). Cardiac magnetic resonance measured cardiac function. Higher CXCR4 signal at 1 and 3 days independently predicted worse functional outcome at 6 weeks (rpartial = -0.4, P = 0.04). Mice were treated with CXCR4 blocker AMD3100 following the imaging timecourse. On-peak CXCR4 blockade at 3 days lowered LV rupture incidence vs. untreated MI (8% vs. 25%), and improved contractile function at 6 weeks (+24%, P = 0.01). Off-peak CXCR4 blockade at 7 days did not improve outcome. Flow cytometry analysis revealed lower LV neutrophil and Ly6Chigh monocyte content after on-peak treatment. Patients (n = 50) early after MI underwent CXCR4 PET imaging and functional assessment. Infarct CXCR4 expression in acute MI patients correlated with contractile function at time of PET and on follow-up. CONCLUSION: Positron emission tomography imaging identifies early CXCR4 up-regulation which predicts acute rupture and chronic contractile dysfunction. Imaging-guided CXCR4 inhibition accelerates inflammatory resolution and improves outcome. This supports a molecular imaging-based theranostic approach to guide therapy after MI.
引用
- Hess A, Derlin T, Koenig T, et al. Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4. Eur Heart J. 2020. PMID: 32901270. doi:10.1093/eurheartj/ehaa598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。